510(k) Report

510(k) · Cleared

Cleared

EquivaBone Osteoinductive Bone Graft Substitute (EquivaBone )

K243609510(k) SpecialCleared Dec 18, 202426-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Etex Corporation · MQV Filler, Bone Void, Calcium Compound

Cleared on Dec 18, 2024 as substantially equivalent to K101557 (Etex Corp., 2010) and 1 other predicate after a 26-day review. Its family tree reaches back 10 generations to 1996.

Decided
Dec 18, 2024
Review
26 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
2

Its longest line of descent runs back 10 generations to K960978 (1996). 40 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 10 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
  2. 6 generations between
  3. 3 generations backK090855 Equivabone Osteoinductive Bone Graft SubstituteEtex Corp. · 2009
  4. 2 generations backK093447 CarrigenEtex Corp. · 2010
  5. 1 generation backK101557 Gamma-BSM, Beta-BSM, Equivabone, CarigenEtex Corp. · 2010
  6. This deviceK243609 EquivaBone Osteoinductive Bone Graft Substitute (EquivaBone )Etex Corporation · 2024
Show all 10 generations
  1. Root · 10 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
  2. 9 generations backK980817 Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model…Interpore Intl. · 1998
  3. 8 generations backK021336 Novabone-Resorbable Bone Graft SubstituteNovabone Products, LLC · 2002
  4. 7 generations backK052494 Novabone-Bioactive Synthetic GraftNovabone Products, LLC · 2005
  5. 6 generations backK072184 Vitoss Bioactive Foam Bone Graft SubstituteOrthovita, Inc. · 2007
  6. 5 generations backK081439 Vitoss Bioactive Foam Pack Bone Graft SubstituteOrthovita, Inc. · 2008
  7. 4 generations backK083033 Vitoss Bone Graft Substitute, Bone Graft Substitute Filled Canister…Orthovita, Inc. · 2008
  8. 3 generations backK090855 Equivabone Osteoinductive Bone Graft SubstituteEtex Corp. · 2009
  9. 2 generations backK093447 CarrigenEtex Corp. · 2010
  10. 1 generation backK101557 Gamma-BSM, Beta-BSM, Equivabone, CarigenEtex Corp. · 2010
  11. This deviceK243609 EquivaBone Osteoinductive Bone Graft Substitute (EquivaBone )Etex Corporation · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−10K960978Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc1996—
−9K980817Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05…Interpore Intl.1998—
−8K021336Novabone-Resorbable Bone Graft SubstituteNovabone Products, LLC2002—
−7K052494Novabone-Bioactive Synthetic GraftNovabone Products, LLC2005—
−6K072184Vitoss Bioactive Foam Bone Graft SubstituteOrthovita, Inc.2007—
−5K081439Vitoss Bioactive Foam Pack Bone Graft SubstituteOrthovita, Inc.2008—
−4K083033Vitoss Bone Graft Substitute, Bone Graft Substitute Filled Canister, Foam &…Orthovita, Inc.2008—
−3K090855Equivabone Osteoinductive Bone Graft SubstituteEtex Corp.2009—
−2K093447CarrigenEtex Corp.2010—
−1K101557Gamma-BSM, Beta-BSM, Equivabone, CarigenEtex Corp.2010—
0 (this device)K243609EquivaBone Osteoinductive Bone Graft Substitute (EquivaBone )Etex Corporation2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
200010
200130
200210
200350
200430
200540
200610
200750
200820
200940
FIG. 1 — Lineage of K243609, 1996–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K101557Gamma-BSM, Beta-BSM, Equivabone, Carigen
Summary page 5
…r device Filler, Bone Void, Calcium Compound 888.3045 MQV, MBP 21 CFR 807.92(a)(3) Predicate # Predicate Trade Name (Primary Predicate is listed first) Product Code K101557 EquivaBone Osteoinductive Bone Graft Substitute MQV, MBP K082793 InterGro DBM (Putty, Paste, Plus) MQV, MBP, GXP Device Descript…
Etex Corp.2010—
*K082793Intergro DBM
Summary page 5
…21 CFR 807.92(a)(3) Predicate # Predicate Trade Name (Primary Predicate is listed first) Product Code K101557 EquivaBone Osteoinductive Bone Graft Substitute MQV, MBP K082793 InterGro DBM (Putty, Paste, Plus) MQV, MBP, GXP Device Description Summary 21 CFR 807.92(a)(4) EquivaBone is a biocompatible b…
Biomet Spine2009—

Also cleared against K101557: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 28 years and passes through 6 companies; a new generation was cleared every 1.9 years on median.
  • 4 of the 40 ancestors have a recall of any class.
  • 4 other devices also cite its predicate K101557.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

EquivaBone is a bone graft substitute that combines synthetic calcium phosphate and demineralized bone. It is resorbed and replaced with new bone during the healing process. It is intended for use to fill bony voids or gaps of the skeletal system of the extremities, spine (i.e. posterolateral spine) and pelvis that are not intrinsic to the stability of the bony structure. These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K243609: EquivaBone Osteoinductive Bone Graft Substitute (EquivaBone ).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K243609

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026